Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
This is a double-blind randomized controlled trial evaluating the effect of perioperative
dual bronchodilator therapy on post-operative pulmonary function and health-related quality
of life (QoL) in mild-to-moderate less symptomatic COPD patients undergoing lung cancer
surgery.
Investigators hypothesized that dual bronchodilator, as compared with placebo, would prevent
reduction of pulmonary function after surgical resection and improve postoperative health
related QoL.